Barclays Boosts Teladoc Health (NYSE:TDOC) Price Target to $29.00
Teladoc Health (NYSE:TDOC – Get Rating) had its price target increased by Barclays from $28.00 to $29.00 in a research note released on Thursday, The Fly reports.
Several other brokerages also recently issued reports on TDOC. SVB Leerink upgraded Teladoc